Your Cart

Dr. Isaac Bright

Dr. Isaac Bright joined Imagion Biosystems as Chief Executive Officer in June 2023. Before entering Imagion, Dr. Bright served as Co-Founder, CEO, and Chairman of RubrYc Therapeutics, Inc. before its trade sale to iBio, Inc. (NYSEA: IBIO) in September 2022.  Prior to launching RubrYc, Dr. Bright was Chief Business Officer for molecular diagnostics innovator HealthTell, […]

Geoff Hollis

Geoff recently spent two years as CFO and Company Secretary of Victory Offices Limited, a leading provider of flexible workspace solutions, leading the company through an IPO on the Australian Stock Exchange. Prior to this, Geoff spent 8 years as CFO and Company Secretary with Lifestyle Communities Limited, a fast growing ASX listed provider of […]

Marie Zhang

Marie Zhang

Marie Zhang, PhD, MBA, is a problem-solver and an effective scientific leader specializing in pharmaceutical and research reagent product development. Now overseeing the R&D team at Imagion Biosystems, she is presently directing the development of MagSense technology test reagents. Dr. Zhang brings more than 20 years of diverse industry experience, including significant management and scientific […]

Yalia Jayalakshmi

Yalia Jayalakshmi, Ph.D. (Jaya) is a biopharmaceutical executive with over 25 years of industry experience in the clinical translation of a wide spectrum of drug, device, nanoparticle delivery and diagnostic imaging product candidates in oncology, ophthalmology and other therapeutic areas. Jaya joined Imagion Biosystems in September 2021 and will be leading our global clinical development […]